Mohammad Ajmal Ali

InstitutionKing Saud University
AddressSaudi Arabia
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 7 Covid-19 publications, with a maximum of 2 publications in December 2020 and June 2021
    All Publications
    Bar chart showing 33 publications over 12 distinct years, with a maximum of 5 publications in 2014 and 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Wang L, Wu Y, Yao S, Ge H, Zhu Y, Chen K, Chen WZ, Zhang Y, Zhu W, Wang HY, Guo Y, Ma PX, Ren PX, Zhang XL, Li HQ, Ali MA, Xu WQ, Jiang HL, Zhang LK, Zhu LL, Ye Y, Shang WJ, Bai F. Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein. Acta Pharmacol Sin. 2021 Aug 04. PMID: 34349236.
      Citations: 1     Fields:    
    2. Gurung AB, Ali MA, Lee J, Farah MA, Al-Anazi KM. An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19. Biomed Res Int. 2021; 2021:8853056. PMID: 34258282.
      Citations: 2     Fields:    Translation:HumansCells
    3. Gurung AB, Al-Anazi KM, Ali MA, Lee J, Farah MA. Identification of novel drug candidates for the inhibition of catalytic cleavage activity of coronavirus 3CL-like protease enzyme. Curr Pharm Biotechnol. 2021 Jun 04. PMID: 34097590.
      Citations:    Fields:    
    4. Gurung AB, Ali MA, Lee J, Farah MA, Al-Anazi KM. Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2. J Infect Public Health. 2021 Feb; 14(2):227-237. PMID: 33493919.
      Citations: 2     Fields:    Translation:HumansCells
    5. Gurung AB, Ali MA, Lee J, Farah MA, Al-Anazi KM. The potential of Paritaprevir and Emetine as inhibitors of SARS-CoV-2 RdRp. Saudi J Biol Sci. 2021 Feb; 28(2):1426-1432. PMID: 33281478.
      Citations: 2     
    6. Gurung AB, Ali MA, Lee J, Abul Farah M, Al-Anazi KM. In silico screening of FDA approved drugs reveals ergotamine and dihydroergotamine as potential coronavirus main protease enzyme inhibitors. Saudi J Biol Sci. 2020 Oct; 27(10):2674-2682. PMID: 32837219.
      Citations: 7     
    7. Gurung AB, Ali MA, Lee J, Farah MA, Al-Anazi KM. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 Mpro enzyme through in silico approach. Life Sci. 2020 Aug 15; 255:117831. PMID: 32450166.
      Citations: 37     Fields:    Translation:HumansCellsPHPublic Health